Glioblastoma (GBM) is the most common primary malignant brain tumor and despite optimal
treatment, long‐term survival remains uncommon. GBM can be roughly divided into three …

Background Glioblastoma multiforme (GBM) is one of the most fatal tumors of the central
nervous system with high rate of disease progression, diagnosis, prognosis and low survival …

Diffuse gliomas are lethal tumors of the central nervous system (CNS) characterized by
infiltrative growth, aggressive nature, and therapeutic resistance. The recent 2016 WHO …

Glioblastoma multiforme (GBM) is a devastating tumour with abysmal prognoses. We
desperately need novel approaches to understand GBM biology and therapeutic …

Glioblastoma (GBM) is the most common primary central nervous system tumor and one of
the most lethal cancers worldwide, with morbidity of 5.26 per 100,000 population per year …

Glioblastomas (GBM) are highly aggressive primary brain tumors. Complex and dynamic
tumor microenvironment (TME) plays a crucial role in the sustained growth, proliferation, and …

Background Glioblastomas are lethal brain tumors under the current combinatorial
therapeutic strategy that includes surgery, chemo-and radio-therapies. Extensive changes in …

Recurrent glioblastomas are frequently found near subventricular zone (SVZ) areas of the
brain where neural stem cells (NSCs) reside, and glioblastoma-derived extracellular …

Glioblastoma multiforme (GBM) is the most common primary brain tumor and is without
exception lethal. GBMs modify the immune system, which contributes to the aggressive …

Microglial cells represent the resident immune elements of the central nervous system,
where they exert constant monitoring and contribute to preserving neuronal activity and …